**Charity registration number 1186345** 

**Company registration number CE019591 (England and Wales)** 

## **ALEXANDER JANSONS MYOCARDITIS UK** 

# **ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023** 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **LEGAL AND ADMINISTRATIVE INFORMATION** 

**Trustees** Mr Andris Jansons Mrs Pamela Jansons Mr Tomas Jansons Mr Derek Wilsher Mrs Amanda Wilsher **Charity number** 1186345 **Company number** CE019591 **Registered office** 13A Station Road Beaconsfield Buckinghamshire HP9 1NL **Bankers** Barclays Bank PLC 7 Station Parade Beaconsfield Buckinghamshire HP9 2PH **Independent Examiner** Critchleys Audit LLP Beaver House 23-38 Hythe Bridge Street Oxford OX1 2EP 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **CONTENTS** 

||**Page**|
|---|---|
|Trustees' report|1 - 2|
|Independent examiner's report|3|
|Statement of financial activities|4|
|Balance sheet|5|
|Notes to the financial statements|6 - 10|





## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

The Trustees, who are also directors of the charity for the purposes of the Companies Act, present their annual report and the financial statements of Alexander Jansons Myocarditis UK for the 12 months ended 31st December 2023. 

The financial statements comply with current statutory requirements, the charity’s Constitution and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102). 

## **Objectives and activities** 

The objects of the charity are for the public benefit to relieve the sickness, suffering and distress of those persons (and their families) who are suffering from myocarditis (and other similar related conditions), in particular but not limited to by promoting research into the causes, diagnosis, treatment and prevention of myocarditis. 

The charity raises funds to finance research in accordance with its objects by seeking donations and by organising fundraising events. 

## **Achievements and performance** 

In  2023 the charity raised £163,613 in donations and from fundraising events and £100,000 has been donated to Royal Brompton Hospital to fund research in accordance with the charity’s objectives. 

Event income totalled £18,610 in 2023 which was made up from the annual Jansons rowing event, a silent auction and a reggae night. 

## **Financial review** 

At 31st December 2023 the total of unrestricted reserves of the charity was £89,966. All reserves will be distributed in accordance with the charity’s objectives. 

Reserves are held by the charity to fund research into Myocarditis. No level of reserves are required to be held 

as salary costs are covered by trustee donations. 

Once sufficient reserves have built, a donation will be made from the charity to The Royal Brompton Hospital for the purpose of funding their research into Myocarditis. 

## **Structure, governance and management** 

## **THE CHARITY** 

Alexander Jansons Myocarditis UK is a Charitable Incorporated Organisation, registered as a charity and governed in accordance with its constitution on 14th November 2019. 

## **MEMBERS** 

The trustees have no beneficial interest in the charity. 

Trustees meet at not less than six-monthly intervals to review the charity’s fundraising performance and activities in connection with its objects. 

In line with the charity’s Constitution, the trustees are appointed for an initial period of four years and may be reappointed thereafter. 

Apart from the first charity trustees, every trustee must be appointed by the Founder. If the Founder ceases to be a charity trustee, such appointment shall be by resolution of the charity trustees. Mr Andris Jansons 

Mrs Pamela Jansons Mr Tomas Jansons Mr Derek Wilsher Mrs Amanda Wilsher 

- 1 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **PUBLIC BENEFIT** 

The Trustees confirm that they have complied with the duty in Section 4 of Part 1 of the Charities Act 2006 to have due regard to public benefit guidance published by the Charity Commission in determining the activities undertaken by the Charity. 

The trustees' report was approved by the Board of Trustees. 

.............................. **Mr Andris Jansons** Trustee Dated: ......................... 

- 2 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **INDEPENDENT EXAMINER'S REPORT** 

## **TO THE TRUSTEES OF ALEXANDER JANSONS MYOCARDITIS UK** 

I report to the trustees on my examination of the financial statements of Alexander Jansons Myocarditis UK (the charity) for the year ended 31 December 2023. 

## **Responsibilities and basis of report** 

As the trustees of the charity (and also its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 (the 2006 Act). 

Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination,  I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011 (the 2011 Act). In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act. 

## **Independent examiner's statement** 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

- 1 accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or 

- 2 the financial statements do not accord with those records; or 

- 3 the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or 

- 4 the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102). 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. 


Katherine Wilkes BSc (Hons) FCA Critchleys Audit LLP 

Beaver House 23-38 Hythe Bridge Street Oxford OX1 2EP 

Dated: .........................2/5/24 

- 3 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT** 

## _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

|**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2023**<br>**2023**<br>**Notes**<br>**£**<br>**£**<br>**Income and endowments from:**<br>Donations and legacies<br>**2**<br>71,088<br>108,650<br>Other trading activities<br>**3**<br>18,610<br>-<br>Other income<br>**4**<br>26<br>-<br>**Total income**<br>89,724<br>108,650<br>**Expenditure on:**<br>Raising funds<br>**5**<br>19,789<br>29,614<br>Charitable activities<br>**6**<br>49,730<br>80,000<br>Total expenditure<br>69,519<br>109,614<br>**Net income/(expenditure)**<br>20,205<br>(964)<br>Transfers between<br>funds<br>(964)<br>964<br>**Net movement in**<br>**funds**<br>19,241<br>-<br>**Reconciliation of funds:**<br>Fund balances at 1 January<br>2023<br>70,725<br>-<br>**Fund balances at 31**<br>**December 2023**<br>89,966<br>-|**Total**<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2023**<br>**2022**<br>**2022**<br>**£**<br>**£**<br>**£**<br>179,738<br>18,567<br>120,852<br>18,610<br>31,377<br>-<br>26<br>78<br>-<br>198,374<br>50,022<br>120,852<br>49,403<br>10,798<br>28,653<br>129,730<br>74,893<br>92,199<br>179,133<br>85,691<br>120,852<br>19,241<br>(35,669)<br>-<br>-<br>-<br>-<br>19,241<br>(35,669)<br>-<br>70,725<br>106,394<br>-<br>89,966<br>70,725<br>-|**Total**<br>**2022**<br>**£**<br>139,419<br>31,377<br>78<br>170,874<br>39,451<br>167,092<br>206,543<br>(35,669)<br>-<br>(35,669)<br>106,394<br>70,725|
|---|---|---|



The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. 

- 4 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **BALANCE SHEET** 

## _**AS AT 31 DECEMBER 2023**_ 

|**Notes**<br>**Current assets**<br>Debtors<br>**10**<br>Cash at bank and in hand<br>**Creditors: amounts falling due within**<br>**one year**<br>**11**<br>Net current assets<br>**Income funds**<br>Unrestricted funds|**2023**<br>**£**<br>2,387<br>91,480<br>93,867<br>(3,901)|**£**<br>89,966<br>89,966<br>89,966|**2022**<br>**£**<br>2,387<br>71,814<br>74,201<br>(3,476)|**£**<br>70,725|
|---|---|---|---|---|
|||||70,725|
|||||70,725|



The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 December 2023. 

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. 

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476. 

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. 

The financial statements were approved by the Trustees on ......................... 

.............................. Mr Andris Jansons **Trustee** 

## **Company registration number CE019591** 

- 5 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **NOTES TO THE  FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **1 Accounting policies** 

## **Charity information** 

Alexander Jansons Myocarditis UK is a private company limited by guarantee incorporated in England and Wales. The registered office is 13A Station Road, Beaconsfield, Buckinghamshire, HP9 1NL. 

## **1.1 Accounting convention** 

The financial statements have been prepared in accordance with the charity's governing document,  the Companies Act 2006, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102. 

The charity has taken advantage of the provisions in the SORP for charities not to prepare a Statement of Cash Flows. 

## **1.2 Going concern** 

The accounts are prepared on a going concern basis. As at the balance sheet date of 31st December 2023 the charitable charity had net assets of £89,966 which the trustees consider are sufficient. The only committed spending is for salaries, which is covered by ongoing donations from a trustee. Once reserves have built up a donation is made to the Royal Brompton Hospital. 

## **1.3 Incoming resources** 

Incoming resources are included in the Statement of Financial Activities when the charity is legally entitled to the income and the amount can be quantified with reasonable accuracy. 

## **1.4 Resources expended** 

Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. 

## **1.5 Taxation** 

The charity is exempt from corporation tax on its charitable activities. 

## **1.6 Fund accounting** 

Unrestricted funds can be used in accordance with charitable objectives at the discretion of the trustees. 

Restricted funds are donated by a trustee and are to be used to cover the payroll costs. Any surplus in the year is transferred to unrestricted income. 

## **2 Donations and legacies** 

||**Unrestricted**|**Restricted**|**Total**|**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|---|---|---|
||**funds**|**funds**||**funds**|**funds**||
||**2023**|**2023**|**2023**|**2022**|**2022**|**2022**|
||**£**|**£**|**£**|**£**|**£**|**£**|
|Donations and gifts|71,088|108,650|179,738|18,567|120,852|139,419|



- 6 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **3 Income from other trading activities** 

||**Unrestricted**|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2023**|**2022**|
||**£**|**£**|
|Fundraising events|18,610|31,377|



## **4 Other income** 

|Interest<br>**Raising funds**<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2023**<br>**2023**<br>**£**<br>**£**<br>Independent examination<br>2,300<br>-<br>Bank charges<br>156<br>-<br>Office expenses<br>1,065<br>-<br>Postage<br>38<br>-<br>Advertising and<br>promotion<br>7,122<br>-<br>Website design and<br>maintenance<br>8,157<br>-<br>Fundraising staff costs<br>-<br>29,614<br>Travel expenses<br>951<br>-<br>Raising funds<br>19,789<br>29,614|**Unrestricted**<br>Unrestricted<br>**funds**<br>funds<br>**2023**<br>2022<br>**£**<br>£<br>26<br>78<br>**Total**<br>Unrestricted<br>Restricted<br>Total<br>funds<br>funds<br>**2023**<br>2022<br>2022<br>2022<br>**£**<br>£<br>£<br>£<br>2,300<br>2,100<br>-<br>2,100<br>156<br>196<br>-<br>196<br>1,065<br>-<br>-<br>-<br>38<br>112<br>-<br>112<br>7,122<br>4,391<br>-<br>4,391<br>8,157<br>3,838<br>-<br>3,838<br>29,614<br>-<br>28,653<br>28,653<br>951<br>161<br>-<br>161<br>49,403<br>10,798<br>28,653<br>39,451|**Unrestricted**<br>Unrestricted<br>**funds**<br>funds<br>**2023**<br>2022<br>**£**<br>£<br>26<br>78<br>**Total**<br>Unrestricted<br>Restricted<br>Total<br>funds<br>funds<br>**2023**<br>2022<br>2022<br>2022<br>**£**<br>£<br>£<br>£<br>2,300<br>2,100<br>-<br>2,100<br>156<br>196<br>-<br>196<br>1,065<br>-<br>-<br>-<br>38<br>112<br>-<br>112<br>7,122<br>4,391<br>-<br>4,391<br>8,157<br>3,838<br>-<br>3,838<br>29,614<br>-<br>28,653<br>28,653<br>951<br>161<br>-<br>161<br>49,403<br>10,798<br>28,653<br>39,451|
|---|---|---|
|||Total<br>2022<br>£<br>2,100<br>196<br>-<br>112<br>4,391<br>3,838<br>28,653<br>161|
|||39,451|



- **5 Raising funds** 

- 7 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **6 Charitable activities** 

|**Funds**<br>**donated**<br>**Charitable**<br>**Expenditure**<br>**2023**<br>**2023**<br>**£**<br>**£**<br>Events<br>-<br>13,605<br>Other donor related<br>activities<br>-<br>16,125<br>Donations to Royal<br>Brompton Hospital<br>80,000<br>20,000<br>80,000<br>49,730<br>**Analysis by fund**<br>Unrestricted funds<br>-<br>49,730<br>Restricted funds<br>80,000<br>-<br>80,000<br>49,730|**Total**<br>**2023**<br>**Funds**<br>**donated**<br>**Charitable**<br>**Expenditure**<br>**2022**<br>**2022**<br>**£**<br>**£**<br>**£**<br>13,605<br>-<br>17,092<br>16,125<br>-<br>-<br>100,000<br>150,000<br>-<br>129,730<br>150,000<br>17,092<br>49,730<br>57,801<br>17,092<br>80,000<br>92,199<br>-<br>129,730<br>150,000<br>17,092|**Total**<br>**2022**<br>**£**<br>17,092<br>-<br>150,000|
|---|---|---|
|||167,092|
|||74,893<br>92,199|
|||167,092|



## **7 Trustees** 

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year. 

## **8 Employees** 

The average monthly number of employees during the year was: 

|Fundraising<br>**Employment costs**<br>Wages and salaries|**2023**<br>**Number**<br>1<br>**2023**<br>**£**<br>29,614|**2022**<br>**Number**<br>1|
|---|---|---|
|||**2022**<br>**£**<br>28,653|



There were no employees whose annual remuneration was more than £60,000. 

## **Remuneration of key management personnel** 

The remuneration of key management personnel is as follows. 

## **9 Taxation** 

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. 

- 8 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

## **10 Debtors** 

|**10**<br>**Debtors**|||
|---|---|---|
|**Amounts falling due within one year:**<br>Trade debtors<br>**11**<br>**Creditors: amounts falling due within one year**<br>Accruals|**2023**<br>**£**<br>2,387<br>**2023**<br>**£**<br>3,901|**2022**<br>**£**<br>2,387|
|||**2022**<br>**£**<br>3,476|



## **12 Restricted funds** 

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used. 

|**At 1**<br>Payroll Fund<br>**Previous year:**<br>**At 1**<br>Payroll Fund|**January**<br>**2023**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**Transfers**<br>**At 31**<br>**December**<br>**2023**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-<br>108,650<br>(109,614)<br>964<br>-<br>**January**<br>**2022**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**Transfers**<br>**At 31**<br>**December**<br>**2022**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>-<br>120,852<br>(120,852)<br>-<br>-|
|---|---|



## **13 Unrestricted funds** 

The funds of the charity include the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes: 

||**At**|**1**|**January**|**Incoming**|**Resources**|**Transfers**|**At 31**|
|---|---|---|---|---|---|---|---|
||||**2023**|**resources**|**expended**||**December**|
||||||||**2023**|
||||**£**|**£**|**£**|**£**|**£**|
|General funds|||70,725|89,724|(69,519)|(964)|89,966|



- 9 - 



## **ALEXANDER JANSONS MYOCARDITIS UK** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2023**_ 

|**13**|**Unrestricted funds**||||||**(Continued)**|
|---|---|---|---|---|---|---|---|
||**Previous year:**|**At 1 January**||**Incoming**|**Resources**|**Transfers**|**At 31**|
||||**2022**|**resources**|**expended**||**December**|
||||||||**2022**|
||||**£**|**£**|**£**|**£**|**£**|
||The Royal Brompton Hospital||9,000|(9,000)|-|-|-|
||General funds||97,394|59,022|(85,691)|-|70,725|
|||106,394||50,022|(85,691)|-|70,725|
|**14**|**Analysis of net assets between**|**funds**||||||
||||||||**Unrestricted**|
||||||||**funds**|
||||||||**2023**|
||||||||**£**|
||**Fund balances at 31 December**|**2023 are represented by:**||||||
||Current assets/(liabilities)||||||89,966|
||||||||89,966|
||||||||**Unrestricted**|
||||||||**funds**|
||||||||**2022**|
||||||||**£**|
||**Fund balances at 31 December**|**2022 are represented by:**||||||
||Current assets/(liabilities)||||||70,725|
||||||||70,725|



## **15 Related party transactions** 

In the period, £29,614 (2022: £26,262) was donated by one trustee and this donation was restricted to cover payroll costs. 

No trustees were reimbursed in the year (2022: No trustees reimbursed). 

- 10 - 

